A recent study conducted by researchers at Dartmouth's Geisel School of Medicine and Thayer School of Engineering has shed light on the role of antibodies in fighting herpes simplex virus (HSV) infections.
These findings, published in Cell Reports Medicine on February 12, 2024, could pave the way for new treatments or vaccines for neonatal herpes.
In their experiments, the research team used a neonatal mouse model to mimic human neonatal infections, engineering antibodies with different properties to explore how they mediate protection.
Do Antibodies Help Vaccines Protect Against Herpes
Frexalimab Has Favorable Effect on Relapsing Multiple Sclerosis
Generally favorable effect seen in terms of number of new gadolinium-enhancing T1-weighted lesions at week 12
Prepandemic Physical Activity Tied to COVID-19 Diagnosis
In addition to lower risk for infections, sufficient physical activity tied to lower hospitalization
Insomnia Found to Be Common Among Nonhospitalized COVID-19 Survivors
Risk for insomnia even higher for those with depression or anxiety
COVID-19 Tied to Significant Increase in Outpatient Health Care
Increases in outpatient visits persist at lower levels through 12 months
COVID-19 mRNA Vaccines Safe During Pregnancy
In a large study, there were lower odds of neonatal mortality associated with vaccination
More Countries Release Genetically Modified Mosquitoes to Curtail Diseases
In 2023, mosquitoes in southeast Brazil transmitted diseases like dengue and Zika, which posed a significant public health issue.
The World Health Organization reported that dengue cases reached an all-time high in 2024, with over 5,000 deaths globally, and Zika cases were once again confirmed in various South American countries.
Unfortunately, recent data indicates that disease outbreaks will be similar in 2024.
However, scientists are working on a genetic-modifying solution to this massive problem.
Ebola Vaccination Reduces Infected People Mortality By 50%
In the 40 years since the Ebola virus was first identified in Africa, there has been a steady increase in the frequency, size, and mortality of epidemics.
After years of antidotal data, a new Doctors Without Borders/Médecins Sans Frontières (MSF) study published in The Lancet Infectious Diseases shows that being vaccinated, even after being exposed to the Ebola virus, can cut mortality figures of those infected by about 52%.
Ebola Vaccination Reduces Mortality 50% for Infected People
In the 40 years since the Ebola virus was first identified in Africa, there has been a steady increase in the frequency, size, and mortality of epidemics.
After years of antidotal data, a new Doctors Without Borders/Médecins Sans Frontières (MSF) study published in The Lancet Infectious Diseases shows that being vaccinated, even after being exposed to the Ebola virus, can cut mortality figures of those infected by about 52%.
National Public Health Strategy Released to Prevent and Control Vector-Borne Diseases
The U.S. Department of Health and Human Services (HHS) recently released the National Public Health Strategy to Prevent and Control Vector-Borne Diseases in People.
These diseases, Lyme, Zika, West Nile virus, dengue, and malaria, have doubled their negative impact on society over the last two decades.
To combat this public health threat, a comprehensive and sustained national effort to protect people is required.